What is Famotidine USP?
Famotidine USP refers to famotidine that meets the standards set by the United States Pharmacopeia (USP). The USP establishes public standards for medicines, food, and dietary supplements, ensuring their quality, purity, and strength [1]. Therefore, famotidine USP is a pharmaceutical-grade version of famotidine that has been manufactured and tested to comply with these rigorous USP specifications.
What is the difference between famotidine and famotidine USP?
The primary distinction between "famotidine" and "famotidine USP" lies in the assurance of quality and adherence to official standards. "Famotidine" as a general term can refer to the active pharmaceutical ingredient itself. However, "famotidine USP" specifically indicates that the substance conforms to the monograph requirements published by the United States Pharmacopeia [1]. This includes detailed specifications for identity, strength, quality, purity, packaging, and labeling, ensuring a reliable and consistent product for medicinal use [1].
How does famotidine work to reduce stomach acid?
Famotidine is a histamine H2 receptor antagonist. It works by blocking the action of histamine on parietal cells in the stomach lining [2]. Histamine stimulates these cells to produce acid. By inhibiting histamine's effects, famotidine reduces the amount of acid secreted into the stomach [2]. This reduction in stomach acid is beneficial for treating conditions such as heartburn, acid indigestion, and peptic ulcers.
When does the patent for famotidine expire?
Famotidine has been available for many years and is now a generic medication. Its original patents have long expired, allowing for the widespread availability of generic versions [3]. Information on specific patent expiry dates for older drugs like famotidine can be found on resources such as DrugPatentWatch.com [3].
Are there other medications similar to famotidine?
Yes, other medications are also used to reduce stomach acid and treat related conditions. These include other H2 receptor antagonists, such as cimetidine and ranitidine (though ranitidine has faced recalls due to impurity concerns) [4]. Another class of drugs used for acid reduction are proton pump inhibitors (PPIs), which include medications like omeprazole, lansoprazole, and esomeprazole. PPIs are generally considered more potent acid reducers than H2 blockers [5].
---
Sources:
1. https://www.usp.org/
2. https://www.drugpatentwatch.com/drug/famotidine
3. https://www.drugpatentwatch.com/
4. https://www.fda.gov/drugs/drug-recalls/certain-ranitidine-products-recalled
5. https://www.mayoclinic.org/diseases-conditions/heartburn/in-depth/heartburn-relief/art-20047473